Literature DB >> 18714010

Molecular requirements for MHC class II alpha-chain engagement and allelic discrimination by the bacterial superantigen streptococcal pyrogenic exotoxin C.

Katherine J Kasper1, Wang Xi, A K M Nur-Ur Rahman, Mohammed M Nooh, Malak Kotb, Eric J Sundberg, Joaquín Madrenas, John K McCormick.   

Abstract

Superantigens (SAgs) are microbial toxins that bind to both TCR beta-chain variable domains (Vbetas) and MHC class II molecules, resulting in the activation of T cells in a Vbeta-specific manner. It is now well established that different isoforms of MHC II molecules can play a significant role in the immune response to bacterial SAgs. In this work, using directed mutational studies in conjunction with functional analyses, we provide a complete functional map of the low-affinity MHC II alpha-chain binding interface of the SAg streptococcal pyrogenic exotoxin C (SpeC) and identify a functional epitope in the beta-barrel domain that is required for the activation of T cells. Using cell lines that exclusively express individual MHC II isoforms, our studies provide a molecular basis for the selectivity of SpeC-MHC II recognition, and provide one mechanism by how SAgs are capable of distinguishing between different MHC II alleles.

Mesh:

Substances:

Year:  2008        PMID: 18714010     DOI: 10.4049/jimmunol.181.5.3384

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  The T cell receptor beta-chain second complementarity determining region loop (CDR2beta governs T cell activation and Vbeta specificity by bacterial superantigens.

Authors:  A K M Nur-ur Rahman; Daniel A Bonsor; Christine A Herfst; Fraser Pollard; Michael Peirce; Aaron W Wyatt; Katherine J Kasper; Joaquín Madrenas; Eric J Sundberg; John K McCormick
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

Review 2.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

3.  MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.

Authors:  Christopher R Shaler; Joshua Choi; Patrick T Rudak; Arash Memarnejadian; Peter A Szabo; Mauro E Tun-Abraham; Jamie Rossjohn; Alexandra J Corbett; James McCluskey; John K McCormick; Olivier Lantz; Roberto Hernandez-Alejandro; S M Mansour Haeryfar
Journal:  PLoS Biol       Date:  2017-06-20       Impact factor: 8.029

4.  Enhanced nasopharyngeal infection and shedding associated with an epidemic lineage of emm3 group A Streptococcus.

Authors:  Baharak Afshar; Claire E Turner; Theresa L Lamagni; Ken C Smith; Ali Al-Shahib; Anthony Underwood; Matthew T G Holden; Androulla Efstratiou; Shiranee Sriskandan
Journal:  Virulence       Date:  2017-05-01       Impact factor: 5.882

5.  Staphylococcal and Streptococcal Superantigens Trigger B7/CD28 Costimulatory Receptor Engagement to Hyperinduce Inflammatory Cytokines.

Authors:  Andrey Popugailo; Ziv Rotfogel; Emmanuelle Supper; Dalia Hillman; Raymond Kaempfer
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

6.  T cell Receptor Vβ9 in Method for Rapidly Quantifying Active Staphylococcal Enterotoxin Type-A without Live Animals.

Authors:  Reuven Rasooly; Paula Do; Xiaohua He; Bradley Hernlem
Journal:  Toxins (Basel)       Date:  2019-07-10       Impact factor: 4.546

Review 7.  Staphylococcal superantigens in colonization and disease.

Authors:  Stacey X Xu; John K McCormick
Journal:  Front Cell Infect Microbiol       Date:  2012-04-17       Impact factor: 5.293

8.  Control of established colon cancer xenografts using a novel humanized single chain antibody-streptococcal superantigen fusion protein targeting the 5T4 oncofetal antigen.

Authors:  Kelcey G Patterson; Jennifer L Dixon Pittaro; Peter S Bastedo; David A Hess; S M Mansour Haeryfar; John K McCormick
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.